期刊文献+

造影剂所致肾损伤及相关问题的评价与处理 被引量:2

Evaluation and Management on Contrast Media-induced Renal Injury
下载PDF
导出
摘要 目的:探讨临床使用造影剂引起肾损伤等安全性问题及相应对策。方法:针对目前临床使用造影剂引起药物相关不良反应发生率逐年攀升的问题,分析造影剂引起肾损害及相关问题的主要原因。结果:对造影剂使用引起造影剂肾病、肾源性系统纤维化、特异性反应以及临床常见的含碘造影剂皮试问题、造影剂局部渗漏等进行阐述,提出针对性的预防处理方法。结论:医护人员应重视临床使用造影剂的安全性问题,加强用药评估、监测及护理工作,避免造影剂相关严重不良反应的发生。 OBJECTIVE: To discuss the problems related to the safety and coping strategy of contrast media - induced renal injury. METHODS : In view of the year - on - year increase of the incidence of the adverse drug reactions induced by contrast media, we analyzed the main reasons accountable for renal injury and the related problems induced by contrast media. RESULTS: Contrast media- induced radiographic contrast nephropathy, nephrogenic systemic fibrosis, specific reaction, and the problems such as skin test of iodine contrast media and local leakage were expounded respectively, and the corresponding preventive treatment was put forward. CONCLUSION: Medical staff should give importance to the safety of contrast media as well as the evaluation, monitoring and nursing in clinical use of contrast media so as to avoid the occurrence of serious adverse drug reactions induced by contrast media.
出处 《中国医院用药评价与分析》 2009年第5期399-400,共2页 Evaluation and Analysis of Drug-use in Hospitals of China
关键词 肾损害 造影剂 原因 对策 Renal injury Contrast media Reason Coping strategy
  • 相关文献

参考文献9

  • 1李菲,韩雅玲,张进,彭岩松.造影剂肾病患者的预防护理[J].中国实用护理杂志(下旬版),2008,24(11):59-60. 被引量:2
  • 2Kelly AM, Dwamena B, Cronin P, et al. Meta - analysis: effectiveness of drugs for preventing contrast - induced neohrooathv[J] . Ann Intern Med ,2008,148(4):284.
  • 3Daram SR, Cortese CM, Bastani B. Nephrogenic fibrosing dermopathy/ nephrogenic systemic fibrosis: report of a new case with literature review [ J ]. Am J Kidney Dis, 2005,46 (4) : 754.
  • 4Boyd AS, Zic JA, Abraham JL. Gadolinium deposition in nephrogenic fibrosing dermopathy [J]. J Am Acad Dermatol , 2007,56(1) : 27.
  • 5Grobner T. Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis[J]? Nephrol Dial Transplant ,2006,21(4) : 1 104.
  • 6Perazella MA. Gadolinium- induced nephrogenic systemic fibrosis in patients with kidney disease[J]. Am J Med,2007, 120(7): 561.
  • 7张蕊,陈泽莲,徐王廷,唐尧.碘造影剂的安全性探讨[J].中国药房,2008,19(23):1830-1832. 被引量:13
  • 8丁尧海(综述),陈海英(综述),张爱平(审校).造影剂肾病的危险因素和预防[J].国际泌尿系统杂志,2007,27(1):121-124. 被引量:4
  • 9Solomon R. The role of osmolality in the incidence of contrast - induced nephropathy: a systematic review of angiographic contrastmedia in high risk patients [ J]. Kidney Int, 2005,68 (5) : 2 256.

二级参考文献45

  • 1刘艳萍,赫金平.对含碘造影剂皮试方法的探讨[J].中国实用护理杂志,2004,20(7):60-60. 被引量:18
  • 2王玉芹,蒿,傅承桦,全勇,周丽娜.碘造影剂过敏试验方法及结果判断标准的研究[J].河北医学,2005,11(11):967-970. 被引量:6
  • 3曹绒霞,王养民,乔够梅.碘造影剂推注过程中不良反应观察[J].西北国防医学杂志,2006,27(4):303-303. 被引量:2
  • 4王锦玲,王安平,孙丽,黄津芳.CT增强检查前患者焦虑情绪的调查分析与护理干预[J].现代护理,2006,12(22):2128-2129. 被引量:15
  • 5李霞 刘钟生.造影剂迟发性副作用分析[J].国外医学:护理学分册,1999,18(2):91-92.
  • 6Liistro F,Falsini G,Bolognese L.The clinical burden of contrast media-induced nephropathy.Ital Heart,2003,4(10):668 -76.
  • 7Dangas G,Iakovou I,Nikolsky E,et al.Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables.American Journal of Cardiology.2005,95(1):13 -19.
  • 8Habeb M,Agac MT,Aliyev F,et al.Contrast media-induced nephropathy:clinical burden and current attempts for prevention,Anadolu Kardiyol Derg,2005,5 (2):124-9.
  • 9Morcos SK.Prevention of contrast media nephrotoxicity-the story so far.Clin Radiol,2004,59:381-9.
  • 10Rich MW,Crecelius CA.Incidence,risk factors,and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older.A prospective study.Arch Intern Med,1990,150(6):1237 -42.

共引文献14

同被引文献4

引证文献2

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部